<DOC>
	<DOC>NCT01314664</DOC>
	<brief_summary>The purpose of this study is to observe and describe the effectiveness and local tolerability of intravesical treatment with valrubicin for non-muscle invasive bladder cancer (NMIBC) in a cohort of subjects treated under routine practice conditions.</brief_summary>
	<brief_title>A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Valrubicin</mesh_term>
	<criteria>Males and females 18 years of age and older Diagnosed with NMIBC Prescribed intravesical valrubicin to treat NMIBC Understood and signed Informed Consent to participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Non-Muscle Invasive Bladder Cancer</keyword>
	<keyword>CIS</keyword>
	<keyword>BCG Refractory</keyword>
</DOC>